Lipigon Pharmaceuticals AB

We are lipid biology experts focusing on developing novel therapeutics for patients with lipid related disorders. Lipigon develops pharmaceuticals that are first- or best-in-class. Unrestricted by technological approach Lipigon addresses unmet medical needs in the field of lipid disorder driven metabolic disease; e.g. indications in the cardiometabolic space and liver diseases such as NASH/NAFLD. Our primary focus is rare orphan lipid driven disorders where we have two active programs for various dyslipidemias and lipodystrophy. Our mission is to develop safe and efficient treatments for lipid related disorders in the orphan disease space where no or few approved treatments exist; thus,...

Drug discovery,dyslipidemia and and other cardiometabolic risk markers,and lipoprotein lipase

Lipigon pharmaceuticals ab operates in the Research services industry.

Lipigon pharmaceuticals ab's revenue is 1m - 10m

Lipigon pharmaceuticals ab has 11 - 50 employees.